Get the Weekly Intelligence Brief — top committee picks every Sunday.

ALC vs GMAB

Alcon Inc vs Genmab A/S — AI-powered side-by-side comparison
ALC
Alcon Inc
68
Buy
VS
GMAB
Genmab A/S
60
Buy
MetricALCGMAB
AI Score 68 60
Price $75.39 $30.82
P/E Ratio 45.39× 24.04×
ROE 4.4% 16.5%
Revenue Growth YoY
Gross Margin 54.9% 39.9%
Debt / Equity 0.24× 0.89×
Dividend Yield 0.5% 0.0%
RSI (14) 73.4 72.5
Beta 0.703 0.685
Expected Upside +11.3%

AI Committee View

Current Innellis committee reasoning for ALC versus GMAB.
ALC leads by 8 points.

ALC scores 68/100 (Buy) versus GMAB at 60/100 (Buy).

ALC Committee View
75% agreement
4 analysts

The primary driver is quarter-over-quarter growth rate is accelerating, not just positive. The main limiting factor is rsi at 73 is in overbought territory. The committee is constructive but not yet at full conviction.

Bull Case
  • Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
  • MACD histogram positive -- bullish momentum — Technical
  • VIX regime is low -- calm backdrop supports risk-taking — Macro
Bear Case
  • RSI at 73 is in overbought territory — Technical
  • Price trading above the upper Bollinger Band -- stretched — Technical
GMAB Committee View
60% agreement
5 analysts

Positive signals support the current rating — vix regime is low -- calm backdrop supports risk-taking. The committee sees sufficient evidence to maintain the constructive view.

Bull Case
  • Price structure making higher highs and higher lows — Technical
  • MACD histogram positive -- bullish momentum — Technical
  • Weekly trend (uptrend) confirms the daily trend -- multi-timeframe agreement — Technical
Bear Case
  • EPS declining -25.3% YoY despite any revenue growth — Growth
  • RSI at 73 is in overbought territory — Technical
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
ALC Full Analysis GMAB Full Analysis